{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T14:28:54Z","timestamp":1763994534805,"version":"3.45.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,24]]},"DOI":"10.7759\/cureus.97651","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T14:26:17Z","timestamp":1763994377000},"source":"Crossref","is-referenced-by-count":0,"title":["Adalimumab-Associated Transverse Myelitis Revealing Relapsing-Remitting Multiple Sclerosis in a Patient With Crohn\u2019s Disease: A Case Report"],"prefix":"10.7759","author":[{"given":"Sara S","family":"Gawargeous","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taha","family":"Elsahy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.29399\/npa.27973","article-title":"Multiple sclerosis-like demyelinating lesions during adalimumab treatment in a case with Crohn\u2019s disease","volume":"59","author":"S\u00f6kmen O","year":"2022","unstructured":"S\u00f6kmen O, G\u00f6\u00e7men R, Tuncer A. Multiple sclerosis-like demyelinating lesions during adalimumab treatment in a case with Crohn\u2019s disease. Arch Neuropsychiatry. 2022, 59:341-344. 10.29399\/npa.27973","journal-title":"Arch Neuropsychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2006.01.012","article-title":"Adalimumab-associated optic neuritis","volume":"244","author":"Chung JH","year":"2006","unstructured":"Chung JH, Van Stavern GP, Frohman LP, Turbin RE. Adalimumab-associated optic neuritis. J Neurol Sci. 2006, 244:133-136. 10.1016\/j.jns.2006.01.012","journal-title":"J Neurol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2011.1","article-title":"Monoclonal antibody therapy-associated neurological disorders","volume":"7","author":"Bosch X","year":"2011","unstructured":"Bosch X, Saiz A, Ramos-Casals M, the BIOGEAS Study Group. Monoclonal antibody therapy-associated neurological disorders. Nat Rev Neurol. 2011, 7:165-172. 10.1038\/nrneurol.2011.1","journal-title":"Nat Rev Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.10.1885","article-title":"Onset of multiple sclerosis associated with anti-TNF-\u03b1 therapy","volume":"57","author":"Sicotte NL","year":"2001","unstructured":"Sicotte NL, Voskuhl RR. Onset of multiple sclerosis associated with anti-TNF-\u03b1 therapy. Neurology. 2001, 57:1885-1888. 10.1212\/WNL.57.10.1885","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-017-0742-1","article-title":"CNS Demyelination with TNF-\u03b1 Blockers","volume":"17","author":"Kemanetzoglou E","year":"2017","unstructured":"Kemanetzoglou E, Andreadou E. CNS Demyelination with TNF-\u03b1 Blockers. Curr Neurol Neurosci Rep. 2017, 17:86. 10.1007\/s11910-017-0742-1","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2025.109031","article-title":"Longitudinally extensive transverse myelitis associated with long-term adalimumab therapy: a diagnostic challenge","volume":"256","author":"Vald\u00e9s JM","year":"2025","unstructured":"Vald\u00e9s JM, Roa B, Orellana P, Galleguillos L. Longitudinally extensive transverse myelitis associated with long-term adalimumab therapy: a diagnostic challenge. Clin Neurol Neurosurg. 2025, 256:109031. 10.1016\/j.clineuro.2025.109031","journal-title":"Clin Neurol Neurosurg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/ar4582","article-title":"Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study","volume":"16","author":"Kaltsonoudis E","year":"2014","unstructured":"Kaltsonoudis E, Zikou AK, Voulgari PV, Konitsiotis S, Argyropoulou MI, Drosos AA. Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study. Arthritis Res Ther. 2014, 16:125. 10.1186\/ar4582","journal-title":"Arthritis Res Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419895155","article-title":"PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-\u03b1 therapy-associated demyelinating disorders","volume":"12","author":"Engel S","year":"2019","unstructured":"Engel S, Luessi F, Mueller A, Sch\u00f6pf RE, Zipp F, Bittner S. PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-\u03b1 therapy-associated demyelinating disorders. Ther Adv Neurol Disord. 2019, 12:1756286419895155. 10.1177\/1756286419895155","journal-title":"Ther Adv Neurol Disord"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases","volume":"86","author":"Ramos-Casals M","year":"2007","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Mu\u00f1oz S, et al.. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore. 2007, 86:242-251. 10.1097\/MD.0b013e3181441a68","journal-title":"Medicine (Baltimore"},{"key":"ref10","unstructured":"FDA. Humira (adalimumab) prescribing information. (2023). Accessed: November 15, 2025: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/125057s423lbl.pdf."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/388690-adalimumab-associated-transverse-myelitis-revealing-relapsing-remitting-multiple-sclerosis-in-a-patient-with-crohns-disease-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T14:26:19Z","timestamp":1763994379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/388690-adalimumab-associated-transverse-myelitis-revealing-relapsing-remitting-multiple-sclerosis-in-a-patient-with-crohns-disease-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.97651","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,24]]}}}